Ravicti Approval History 
- FDA approved: Yes (First approved February 1st, 2013)
- Brand name: Ravicti
- Generic name: glycerol phenylbutyrate
- Company: Hyperion Therapeutics
- Treatment for: Urea Cycle Disorders
Ravicti (glycerol phenylbutyrate) is a nitrogen-binding agent for the chronic management of patients with urea cycle disorders.
FDA Approval History for Ravicti
| Date | Article |
|---|---|
| Feb 1, 2013 |  FDA Approves Ravicti for the Chronic Management of Some Urea Cycle Disorders |
See also...
Ravicti (glycerol phenylbutyrate) Consumer Information
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
